MeSH Review:
Quality-Adjusted Life Years
Naeim,
Keeler,
Graham,
Thompson,
Goldie,
Segui-Gomez,
Weinstein,
Bolin,
Lindgren,
Willers,
Mar,
Rodríguez-Artalejo,
Smith,
Roberts,
Bansback,
Brennan,
Ghatnekar,
Gould,
Dembitzer,
Sanders,
Garber,
Heudebert,
Marks,
Wilcox,
Centor,
Gazelle,
Hunink,
Kuntz,
McMahon,
Halpern,
Beinfeld,
Lester,
Tanabe,
Weinstein,
Merkesdal,
Ruof,
Mittendorf,
Zeidler,
- The cost-effectiveness of preventing AIDS-related opportunistic infections. Freedberg, K.A., Scharfstein, J.A., Seage, G.R., Losina, E., Weinstein, M.C., Craven, D.E., Paltiel, A.D. JAMA (1998)
- Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Pinkerton, S.D., Holtgrave, D.R., Pinkerton, H.J. Arch. Intern. Med. (1997)
- Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Gazelle, G.S., Hunink, M.G., Kuntz, K.M., McMahon, P.M., Halpern, E.F., Beinfeld, M., Lester, J.S., Tanabe, K.K., Weinstein, M.C. Ann. Surg. (2003)
- Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? Mar, J., Rodríguez-Artalejo, F. J. Hypertens. (2001)
- Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. Reed, S.D., Radeva, J.I., Glendenning, G.A., Saad, F., Schulman, K.A. J. Urol. (2004)
- The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. Bolin, K., Lindgren, B., Willers, S. Chest (2006)
- Valuing the effects of sildenafil in erectile dysfunction. Strong assumptions are required to generate a QALY value. Freemantle, N. BMJ (2000)
- A cost-effectiveness clinical decision analysis model for schizophrenia. Palmer, C.S., Revicki, D.A., Genduso, L.A., Hamilton, S.H., Brown, R.E. The American journal of managed care. (1998)
- The cost-effectiveness of air bags by seating position. Graham, J.D., Thompson, K.M., Goldie, S.J., Segui-Gomez, M., Weinstein, M.C. JAMA (1997)
- Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. Fiscella, K., Franks, P. JAMA (1996)
- Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. Gage, B.F., Cardinalli, A.B., Albers, G.W., Owens, D.K. JAMA (1995)
- Cost-utility of initial medical management for Crohn's disease perianal fistulae. Arseneau, K.O., Cohn, S.M., Cominelli, F., Connors, A.F. Gastroenterology (2001)
- Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase. Warren, E., Ward, S., Gordois, A., Scuffham, P. Clinical therapeutics. (2004)
- Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness. Kuehne, F.C., Bethe, U., Freedberg, K., Goldie, S.J. Arch. Intern. Med. (2002)
- Etanercept: a pharmacoeconomic review of its use in rheumatoid arthritis. Lyseng-Williamson, K.A., Plosker, G.L. PharmacoEconomics. (2004)
- Cost-effectiveness of prenatal screening for postpartum thyroiditis. Bonds, D.E., Freedberg, K.A. Journal of women's health & gender-based medicine. (2001)
- Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Heudebert, G.R., Marks, R., Wilcox, C.M., Centor, R.M. Gastroenterology (1997)
- Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Gould, M.K., Dembitzer, A.D., Sanders, G.D., Garber, A.M. Ann. Intern. Med. (1999)
- Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Owens, D.K., Sanders, G.D., Harris, R.A., McDonald, K.M., Heidenreich, P.A., Dembitzer, A.D., Hlatky, M.A. Ann. Intern. Med. (1997)
- The cost-effectiveness of sildenafil. Smith, K.J., Roberts, M.S. Ann. Intern. Med. (2000)
- Should postmenopausal women with rheumatoid arthritis who are starting corticosteroid treatment be screened for osteoporosis? A cost-effectiveness analysis. Solomon, D.H., Kuntz, K.M. Arthritis Rheum. (2000)
- Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis. Merkesdal, S., Ruof, J., Mittendorf, T., Zeidler, H. Expert opinion on pharmacotherapy. (2004)
- Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden. Bansback, N.J., Brennan, A., Ghatnekar, O. Ann. Rheum. Dis. (2005)
- A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. Kalish, S.C., Gurwitz, J.H., Krumholz, H.M., Avorn, J. Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine. (1995)
- Economic evaluation of aquatic exercise for persons with osteoarthritis. Patrick, D.L., Ramsey, S.D., Spencer, A.C., Kinne, S., Belza, B., Topolski, T.D. Medical care. (2001)
- Long-term treatment of multiple sclerosis with interferon-beta may be cost effective. Kendrick, M., Johnson, K.I. PharmacoEconomics. (2000)
- Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Catherwood, E., Fitzpatrick, W.D., Greenberg, M.L., Holzberger, P.T., Malenka, D.J., Gerling, B.R., Birkmeyer, J.D. Ann. Intern. Med. (1999)
- Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. Goldie, S.J., Kaplan, J.E., Losina, E., Weinstein, M.C., Paltiel, A.D., Seage, G.R., Craven, D.E., Kimmel, A.D., Zhang, H., Cohen, C.J., Freedberg, K.A. Arch. Intern. Med. (2002)
- Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Klarenbach, S.W., Pannu, N., Tonelli, M.A., Manns, B.J. Crit. Care Med. (2006)
- Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. AuBuchon, J.P., Birkmeyer, J.D., Busch, M.P. Transfusion (1997)
- Is Adjuvant Therapy for Older Patients with Node (+) Early Breast Cancercost-effective?*. Naeim, A., Keeler, E.B. Breast Cancer Res. Treat. (2005)